# Sports bioeconomy Wearables, blood panels and at-home biomarker tests that turn an athlete's own physiology — recovery, blood chemistry, glucose, genetics, urine biomarkers — into an actionable training signal, sold direct-to-consumer as a performance product rather than a clinical diagnostic. Source: https://en.bioecon.ru/technology/sports-bioeconomy/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: US FDA wellness-device exemption + EU IVDR for at-home biomarker testing | OECD: Biotech and health | Regulator: FDA (USA), REACH framework (EU)] Sports bioeconomy covers the wearables, blood panels, genetic tests and at-home biomarker kits that turn an athlete's own physiology into an actionable training signal, sold direct-to-consumer as a performance and recovery product rather than routed through a clinical diagnostic pathway. A modern recovery wearable derives daily readiness scores from continuously measured biomarkers (heart-rate variability, respiratory rate, skin temperature), while an at-home blood panel service tests dozens of biomarkers from a single draw and translates the results into specific training and nutrition recommendations. The category spans wearable recovery tracking, blood-panel performance testing, genetic tests linking specific gene variants to nutrition and training response, continuous glucose monitoring adapted from diabetes care to athletic fueling, and urine biomarker strips paired with a smartphone app for daily wellness tracking. Because these products are marketed and regulated as wellness or performance tools rather than medical devices, the category occupies a distinct regulatory and commercial lane from clinical diagnostics, even where the underlying biomarker assay technology overlaps. The key directions of sports bioeconomy are: 1. **Wearable recovery and readiness tracking:** continuous biomarker measurement (heart-rate variability, respiratory rate, skin temperature) generates a daily recovery and readiness score without a blood draw. 2. **Blood-panel performance testing:** at-home or lab blood-draw services test dozens of biomarkers and translate results into specific training, nutrition and supplementation recommendations. 3. **Genetic testing for nutrition and training response:** DNA tests link specific gene variants to individual nutrition and exercise-response profiles, informing personalized training and diet plans. 4. **Continuous glucose and urine biomarker monitoring:** technology adapted from diabetes care (continuous glucose monitors) and at-home diagnostics (urine test strips) is repositioned for athletic fueling and daily wellness tracking. ### Sectoral value chain ``` [Athlete biomarker source] ──> [Measurement device/assay] ──> [Data collection] │ (biomarker interpretation) │ ▼ [Training/nutrition recommendation] <─── [App/platform delivery] <─── [Personalized analysis] ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Device/assay manufacturing** | Wearable sensors, blood-panel test kits, genetic-test kits or urine test strips are manufactured to a defined measurement specification. | **In:** sensor/assay components. **Out:** manufactured measurement device or kit. | | **Sample/signal collection** | The athlete wears the device continuously or provides a blood, saliva or urine sample. | **In:** manufactured device/kit, athlete. **Out:** raw biomarker signal or sample. | | **Biomarker measurement** | The device or laboratory processes the signal or sample into calibrated biomarker values. | **In:** raw signal/sample. **Out:** calibrated biomarker data. | | **Personalized analysis** | Algorithms or lab interpretation translate biomarker data into an individual recovery score, nutrition profile or training recommendation. | **In:** calibrated biomarker data, individual baseline. **Out:** personalized interpretation. | | **App/platform delivery** | The personalized analysis is delivered to the athlete through a mobile app or web platform. | **In:** personalized interpretation. **Out:** athlete-facing recommendation. | | **Training/nutrition action** | The athlete adjusts training load, nutrition or recovery behavior based on the delivered recommendation. | **In:** athlete-facing recommendation. **Out:** modified training/nutrition behavior. | Cross-cutting technologies of the sector: - **Continuous wearable biomarker sensing:** heart-rate variability, respiratory rate and skin-temperature sensors generate a daily readiness score without requiring a blood draw, enabling continuous rather than point-in-time measurement. - **Direct-to-consumer blood-panel testing:** at-home or retail blood-draw services test dozens of biomarkers in a single panel, translating lab results directly into consumer-facing training and nutrition guidance. - **Repositioned diagnostic technology:** continuous glucose monitors developed for diabetes management and urine test strips developed for clinical screening are repositioned as athletic performance and wellness tools for a non-clinical consumer market. --- ## US The US hosts the leading wearable recovery-tracking company, an at-home blood-panel testing pioneer, a continuous-glucose-monitoring athletic performance company and a urine-biomarker wellness-testing company. ### wearable recovery tracking, blood-panel testing, repositioned diagnostic technology - **WHOOP:** publishes dedicated content on recovery and performance biomarkers and cardiovascular biomarkers for athletes, positioning continuous wearable measurement specifically around training and heart-health guidance. - **InsideTracker:** offers at-home and mobile blood-draw testing with an "Ultimate" membership tier, an established direct-to-consumer blood-panel testing pioneer in the category. - **Supersapiens:** built the first continuous glucose-monitoring system specifically for athletic performance, repositioning diabetes-care sensor technology for non-clinical athletic fueling. - **Vivoo:** offers a 9-in-1 urine test paired with a smartphone app tracking hydration, pH balance, ketone levels and other wellness biomarkers for daily use. --- ## CN No China-headquartered sports bioeconomy company cleared this screening round with confirmed, on-domain evidence. ### import- and distributor-served market - **Screening note:** one candidate China-headquartered sports biomarker company was probed and did not return confirming, on-domain evidence this round — not asserted as absent, only as unconfirmed. --- ## EU This screening round did not confirm a European-headquartered sports bioeconomy company with on-domain evidence distinct from candidates checked elsewhere; the category currently reads as concentrated among US-headquartered wearable, blood-panel and diagnostic-repositioning companies. ### screening limitation - **Screening note:** a UK-based sweat-testing candidate returned confirming evidence only through third-party competitor content rather than its own domain — a false-confirmation, dropped rather than tabled. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **WHOOP** | 🇺🇸 USA | *Recovery/performance and cardiovascular biomarker tracking* | Continuous wearable HRV, respiratory rate, skin temperature | Commercial | | **InsideTracker** | 🇺🇸 USA | *Ultimate blood-panel membership* | At-home/mobile blood draw, dozens of biomarkers | Commercial | | **Nutrigenomix** | 🇨🇦 Canada | *Athlete-focused genetic nutrition test* | Gene-variant-based nutrition/training-response profiling | Commercial | | **Supersapiens** | 🇺🇸 USA | *Continuous glucose monitoring for athletes* | Diabetes-sensor technology repositioned for athletic fueling | Commercial | | **Vivoo** | 🇺🇸 USA | *9-in-1 urine wellness test* | Smartphone-app-paired daily biomarker tracking | Commercial | --- ## Tech stack and innovations The stack layers continuous wearable sensing, direct-to-consumer lab testing and repositioned clinical-diagnostic technology on a common personalized-performance backbone. 1. **Continuous wearable biomarker sensing:** - Heart-rate variability, respiratory rate and skin-temperature sensors generate a daily readiness score without a blood draw, enabling continuous rather than point-in-time measurement. - Dedicated cardiovascular and recovery-biomarker content packages the underlying sensor data into athlete-facing training and heart-health guidance. 2. **Direct-to-consumer blood-panel and genetic testing:** - At-home or mobile blood-draw services test dozens of biomarkers in one panel, translating lab results into consumer-facing recommendations without a clinical visit. - Gene-variant testing links an athlete's genetics to individual nutrition and training-response profiles, personalizing recommendations beyond what a one-size-fits-all blood panel alone provides. 3. **Repositioned diagnostic technology for athletic use:** - Continuous glucose monitors, originally developed for diabetes management, are repositioned as athletic fueling tools for a non-clinical consumer market. - Urine test strips paired with a smartphone app extend at-home diagnostic technology into daily wellness tracking outside a clinical screening context. --- ## Value chains and production pipelines ### Industrial pipeline of sports bioeconomy biomarker delivery (US FDA wellness-device exemption / EU IVDR) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. Device/assay │ ───> │ 2. Sample/signal │ │ manufacturing │ │ collection │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Personalized analysis │ <─── │ 3. Biomarker measurement │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. App/platform delivery │ ───> │ 6. Training/nutrition │ │ │ │ action │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: Device/assay manufacturing Wearable sensors, blood-panel test kits, genetic-test kits or urine test strips are manufactured to a defined measurement specification. #### Stage 2: Sample/signal collection The athlete wears the device continuously or provides a blood, saliva or urine sample. #### Stage 3: Biomarker measurement The device or laboratory processes the signal or sample into calibrated biomarker values. #### Stage 4: Personalized analysis Algorithms or lab interpretation translate biomarker data into an individual recommendation. #### Stage 5: App/platform delivery The personalized analysis is delivered to the athlete through a mobile app or web platform. #### Stage 6: Training/nutrition action The athlete adjusts training load, nutrition or recovery behavior based on the delivered recommendation. ---